Posted in News

Technology Development Fund Accepting Applications!!

The University’s Technology Development Fund is accepting pre-proposal applications from Wednesday, Aug. 1, to Saturday, Sept. 1, for its sixth round of award funding. The fund promotes the transfer and translation of University research into commercial applications through monetary awards ranging from $40,000 to $100,000. In so doing, it enhances the University’s economic impact and its mission of active dissemination of knowledge to society.

The application has been streamlined, allowing therapeutics and vaccines proposals to be evaluated using updated criteria, increasing the chances for an award in this area.

For more information, contact Michael Rusnak, the fund manager, at 784-2935 or visit the fund’s website for additional details.

Advertisements
Posted in News

The University of Rochester Clinical and Translation Science Institutes New Weekly Newsletter!!

The University of Rochester Clinical and Translational Science Institute (CTSI) promotes translational biomedical research to improve human health through new diagnostic techniques, new therapies, advances in clinical practice and new community-based interventions. CTSI advocates this kind of research by encouraging teams of scientists and physicians to tackle tough problems in human health, and by educating the next generation of translational researchers.

CTSI recently created a weekly newsletter to help promote events, foster collaborations, advertise clinical and translational science funding opportunities, and much more.

For a sneak peek and to get involved please visit the CTSI newsletter page!

To learn more about all the wonderful things CTSI has going on please check out the CTSI website!

Posted in News

The Higgs Boson – Hagen Calls CERN Findings a ‘Remarkable Achievement’ but Says More Work Is Needed

Leah Pearson, a graduate student with Prof. Ed Thorndike on the BESIII experiment that is located at the Inst. of High Energy Physics in Beijing, China.

Physicist Carl Hagen, one of the original scientists to develop the theories on the Higgs mechanism and Higgs boson, applauded the apparent success of CERN scientists in finding evidence of the elusive subatomic particle. Hagen was in attendance at CERN’s research facilities near Geneva, Switzerland, on

July 4, when researchers announced the discovery of a new particle that is “consistent with the Higgs boson.”

The announcement was based on the findings of two separate experiments—CMS and Atlas—being conducted at CERN’s Large Hadron Collider (LHC).

“The work is very impressive and is a truly remarkable achievement,” said Hagen. “Yet that is not to say that it is the long-sought boson. Its spin has yet to be determined, for example.”

The Higgs boson, which makes it possible for particles to have mass, is the only particle predicted by the Standard Model of particle physics that has not yet been observed.

His 1964 article, “Global Conservation Laws and Massless Particles,” cowritten by Gerald Guralnik and Thomas Kibble, was named one of the milestone papers in the history of Physical Review Letters.

Hagen traveled to Switzerland for the historic announcement. He described the presentation at CERN as unusual and extraordinary, with the talks “interspersed with bouts of prolonged applause.”

The Higgs boson is believed to be responsible for other particles having mass. It is the only particle predicted by the Standard Model of particle physics that has not yet been observed.

Read more about the July 4 announcement in Science News (July 4, 2012)

For the full article